Carboazidation of Chiral Allylsilanes
FULL PAPER
fonylazide (132 mg, 0.72 mmol), (Bu3Sn)2 (0.18 mL, 0.36 mmol), and
DTBHN (9 mg, 0.05 mmol) added by 3% portion every 90 min. The
crude was purified by chromatography (hexane/EtOAc 95:5) to afford a
yellow oil (syn/anti 77:23, 75 mg, 74%).IR (neat): nmax =3070–2965, 2106,
7.2 Hz, 1H), 4.02 (q, J=7.1 Hz, 1H), 3.72 (m, 1H), 2.20–2.00 (m, 2H),
2.03 (s, 3H), 1.72–1.55 (m, 2H), 1.45–1.31 (m, 1H), 1.19 (t, J=7.2 Hz,
3H), 0.47 (s, 3H), 0.39 ppm (s, 3H); 13C NMR (75 MHz, CDCl3): d=
172.4, 169.8, 140.5, 137.5, 134.0, 129.2, 128.4, 127.9, 127.5, 125.4, 74.1,
62.2, 60.4, 41.8, 31.6, 31.4, 21.4, 14.1, ꢀ2.0, ꢀ2.6 ppm; MS (ESI): m/z
(%): 476 (100) [M+Na]+, 433 (29), 299 (18), 217 (48); HRMS [M+Na]+
C24H31N3O4SiNa calcd: 476.1981; found: 476.1961.
1732, 1427, 1372, 1235, 1112, 837, 817 cmꢀ1 1H NMR (300 MHz, CDCl3),
;
major diastereomer: d=7.58–7.51 (m, 2H), 7.38–7.32 (m, 3H), 4.93 (dd,
J=8.1, 2.1 Hz, 1H), 4.14 (q, J=7.1 Hz, 2H), 3.89 (m, 1H), 2.38 (m, 2H),
2.00 (s, 3H), 1.84 (m, 1H), 1.68 (m, 2H), 1.45 (dd, J=2.0, 1.4 Hz, 1H),
1.26 (t, J=7.2 Hz, 3H), 0.77 (d, J=7.0 Hz, 3H), 0.74 (d, J=7 Hz, 3H),
0.41 (s, 3H), 0.40 ppm (s, 3H); minor diastereomer: d=7.58–7.48 (m,
2H), 7.40–7.32 (m, 3H), 5.03 (dd, J=6.7, 5.2 Hz, 1H), 4.12 (q, J=7.1 Hz,
2H), 3.75 (m, 1H), 2.36 (m, 2H), 2.04 (s, 3H), 1.94 (m, 1H), 1.69 (m,
2H), 1.43 (m, 1H), 1.25 (t, J=7.2 Hz, 3H), 0.81 (d, J=6.8 Hz, 3H), 0.71
(d, J=6.6 Hz, 3H), 0.43 (s, 3H), 0.42 ppm (s, 3H); 13C NMR (75 MHz,
CDCl3), major diastereomer: d=172.8, 170.7, 137.7, 134.2, 129.1, 127.7,
76.8, 63.0, 60.5, 36.5, 32.5, 32.0, 31.7, 21.6, 19.4, 18.5, 14.2, ꢀ2.1,
ꢀ3.1 ppm; minor diastereomer : d?172.7, 170.5, 137.8, 133.7, 129.2, 127.9,
77.0, 62.8, 60.4, 33.7, 32.2, 31.7, 30.3, 21.1, 19.9, 17.5, ꢀ2.3, ꢀ2.4 ppm; MS
(ESI): m/z: 442 (50) [M+Na]+; HRMS [M+Na]+ C21H33N3O4SiNa calcd:
442.2138; found: 442.2137.
Diethyl 2-acetoxy-4-azido-3-(dimethylphenylsilyl)heptanedioate (15 f):
Prepared according to general procedure C from ethyl ester 7 (73 mg,
0.35 mmol), allylsilane 13 f (213 mg, 0.66 mmol), 3-pyridylsulfonylazide
(197 mg, 1.07 mmol), (Bu3Sn)2 (0.25 mL, 0.5 mmol), and DTBHN (10 mg,
0.06 mmol) added by 3% portion every 90 min. The crude was purified
by chromatography (pentane/EtOAc 9:1) to afford a yellow oil (syn/anti
88:12, 54 mg, 34%).Major diastereomer : IR (neat) nmax =3071–2950,
2109, 1740, 1731, 1373, 1113, 817 cmꢀ1 1H NMR (300 MHz, CDCl3): d=
;
7.56–7.49 (m, 2H), 7.40–7.34 (m, 3H), 5.11 (d, J=1.9 Hz, 1H), 4.14 (m,
4H), 3.72 (m, 1H), 2.44–2.24 (m, 2H), 2.03 (s, 3H), 1.86 (m, 1H), 1.78–
1.66 (m, 2H), 1.25 (m, 6H), 0.47 ppm (s, 6H); 13C NMR (75 MHz,
CDCl3): d=172.6, 170.1, 170.0, 136.6, 133.9, 129.5, 128.0, 71.4, 62.9, 61.7,
60.5, 36.7, 31.5, 31.1, 20.9, 14.2, 14.0, ꢀ2.3, ꢀ2.7 ppm; MS (LSIMS): m/z
(%): 472 (30) [M+Na]+, 407 (65) [MꢀN3]+, 372 (26), 235 (22); HRMS
[M+Na]+ C21H31N3O6SiNa calcd: 472.187984; found: 472.187837.
4-Azido-5-(dimethylphenylsilanyl)-7-methyl-6-triethylsilanyloxyoctanoic
acid ethyl ester (15b): Prepared according to general procedure C from
ethoxythiocarbonylsulfanyl-acetic acid ethyl ester 7 (59 mg, 0.283 mmol),
allylsilane 13b (205 mg, 0.566 mmol), benzenesulfonylazide (161 mg,
0.849 mmol), (Bu3Sn)2 (0.21 mL, 0.424 mmol) and DTBHN (9 mg,
0.05 mmol) added by 3% portion every 90 min. The crude was purified
by chromatography (hexane/EtOAc : 98/2) to afford a yellow oil (50/50,
Ethyl
6-acetoxy-4-azido-5-(dimethylphenylsilyl)-6-phenylhexanoate
(16a): Prepared according to general procedure C from ethyl ester 7
(58 mg, 0.278 mmol), allylsilane 14a (151 mg, 0.466 mmol), 3-pyridylsulfo-
nylazide (156 mg, 0.85 mmol), (Bu3Sn)2 (0.18 mL, 0.36 mmol), and
DTBHN (16 mg, 0.09 mmol) added by 3% portion every 90 min. The
crude was purified by chromatography (hexane/EtOAc 95:5) to afford a
colorless oil (syn/anti 83:17, 98 mg, 78%).IR (neat): nmax =3069–2950,
75 mg, 61%).IR (neat)
nmax =2857, 2099, 1738, 1250, 1111 cmꢀ1
;
1H NMR (400 MHz, CDCl3) two diastereomers: d=7.54–7.49 (m, 4H),
7.39–7.30 (m, 6H), 4.17–4.04 (m, 4H), 3.98 (m, 1H), 3.87 (m, 1H), 3.85–
3.79 (m, 2H), 2.48–2.23 (m, 2H), 2.21–2.00 (m, 2H), 1.92-.159 (m, 4H),
1.61-.154 (m, 2H), 1.45–1.31 (m, 2H), 1.29–1.23 (m, 6H), 1.01–0.95 (m,
18H), 0.88 (d, J=6.8 Hz, 3H), 0.80 (d, J=6.8 Hz, 3H), 0.68–0.59 (m,
18H), 0.46 (s, 3H), 0.44 (s, 3H), 0.43–0.41 ppm (m, 6H); 13C NMR
(75 MHz, CDCl3) two diastereomers: d=172.8, 172.8, 139.2, 139.1, 134.1,
133.7, 128.9, 128.8, 127.8, 127.6, 76.3, 75.1, 63.5, 63.0, 60.4, 60.3, 35.8, 35.7,
35.2, 34.8, 32.1, 32.1, 32.0, 30.5, 19.5, 17.7, 17.6, 17.6, 14.2, 7.1, 5.6, 5.6,
ꢀ0.9, ꢀ1.5, ꢀ1.6, ꢀ2.7 ppm; MS (ESI): m/z (%): 514 (100) [M+Na]+,
471 (40); HRMS [M+Na]+ C25H45N3O3Si2Na calcd: 514.2897; found:
514.2892.
2099, 1737, 1229, 1111, 1022 cmꢀ1 1H NMR (250 MHz, CDCl3), major +
;
minor: d=7.60–7.50 (m, 2H), 7.40–7.22 (m, 5H), 6.09 (d, J=7.0 Hz, 1H),
5.93 (d, J=8.5 Hz, 1H), 4.04 (q, J=7.0 Hz, 2H), 3.38 (m, 1H), 2.30–2.06
(m, 2H), 1.96 (s, 3H), 1.95 (m, 2H), 1.89 (s, 3H), 1.76–1.64 (m, 2H), 1.20
(t, J=7.3 Hz, 3H), 1.19 (t, J=7.3 Hz, 3H), 0.46 (s, 3H), 0.41 (s, 3H),
0.34 ppm (s, 3H); 13C NMR (63 MHz, CDCl3) major diastereomer: d=
172.3, 169.4, 140.5, 138.4, 133.8, 129.0, 128.5, 127.9, 127.8, 126.6, 76.2,
63.4, 60.4, 39.6, 31.5, 29.2, 21.1, 14.1, ꢀ1.2, ꢀ1.3 ppm; minor diastereo-
mer: d=172.2, 169.5, 141.1, 138.4, 133.6, 126.4, 74.8, 62.3, 60.4, 38.4, 31.2,
29.3, 21.1, 13.7, ꢀ1.3, ꢀ2.3 ppm; MS (LSIMS): m/z (%): 476 (100)
[M+Na]+, 329 (50), 307 (36), 288 (67); HRMS [M+Na]+
C24H31N3O4SiNa calcd: 476.198155; found: 476.198755.
Ethyl
6-acetoxy-4-azido-7,7-dimethyl-5-(dimethylphenylsilyl)octanoate
(15c): Prepared according to general procedure C from ethyl ester 7
(144 mg, 0.69 mmol), allylsilane 13c (425 mg, 1.4 mmol), 3-pyridylsulfo-
6-Acetoxy-4-azido-5-(dimethylphenylsilanyl)-7-methyloctanoic acid ethyl
ester (16b): Prepared according to general procedure C from ethyl ester
7 (55 mg, 0.265 mmol), allylsilane 14b (154 mg, 0.53 mmol), benzenesul-
fonylazide (145 mg, 0.795 mmol), (Bu3Sn)2 (0.20 mL, 0.4 mmol), and
DTBHN (5 mg, 0.05 mmol) added by 3% portion every 90 min. The
crude was purified by chromatography (hexane/EtOAc : 95/5) to afford a
yellow oil (syn/anti 82:18, 74 mg, 67%).IR (neat) nmax =2970–2874, 2100,
A
DTBHN (22 mg, 0.13 mmol) added by 3% portion every 90 min. The
crude was purified by chromatography (pentane/EtOAc 95:5) to afford a
yellow oil (syn/anti 83:17, 108 mg, corrected yield 72%).IR (neat): nmax
=
3071–2872, 2106, 1738, 1370, 1235, 1113, 1051, 837 cmꢀ1 1H NMR
;
1732, 1427, 1372, 1236, 1112, 838, 817 cmꢀ1 1H NMR (300 MHz, CDCl3),
;
(300 MHz, CDCl3), major + minor: d=7.62–7.53 (m, 2H), 7.39–7.31 (m,
3H), 5.01 (m, 1H), 4.14 (q, J=7.2 Hz, 1H), 4.13 (q, J=7.0 Hz, 1H), 4.07
(m, 1H), 2.51–2.28 (m, 2H), 2.13 (s, 3H), 2.10 (s, 3H) 1.83 (m, 1H), 1.67
(m, 1H), 1.38 (m, 1H), 1.26 (t, J=7.2 Hz, 3H), 1.25 (t, J=7.2 Hz, 3H),
0.69 (s, 9H) 0.67 (s, 9H),0.48 (s, 3H) 0.43 (s, 3H), 0.41 (s, 3H) 0.40 ppm
(s, 3H); 13C NMR (75 MHz, CDCl3), major + minor: d=172.8, 172.7,
170.5, 170.3, 138.0, 137.9, 134.4, 134.2, 129.3, 129.1, 127.8, 127.7, 76.7,
76.5, 63.5, 62.7, 60.5, 60.4, 37.6, 37.2, 34.9, 32.7, 32.4, 32.0, 31.7, 26.2, 26.1,
21.9, 21.0, 14.2, ꢀ2.0, ꢀ2.4, ꢀ2.5, ꢀ3.7 ppm; MS (LSIMS): m/z (%): 456
(100) [M+Na]+, 391 [MꢀN3]+, 349, 305, 288; HRMS [M+Na]+
C22H35N3O4SiNa calcd: 456.229455; found: 456.230196.
major + minor: d=7.61–7.50 (m, 2H), 7.40–7.32 (m, 3H), 5.07 (dd, J=
9.4, 1.5 Hz, 1H), 5.00 (dd, J=9.0, 2.3 Hz, 1H), 4.11 (q, J=7.2 Hz, 2H),
4.06 (q, J=7.1 Hz, 2H), 3.52 (m, 1H), 2.33 (m, 2H), 2.07 (s, 3H), 2.04 (s,
3H), 1.92–1.58 (m, 7H), 1.48 (dd, J=5.4, 1.6 Hz, 1H), 1.23 (t, J=7.2 Hz,
3H), 1.21 (t, J=7.3 Hz, 3H), 0.91 (d, J=6.6 Hz, 3H), 0.89 (d, J=6.4 Hz,
3H), 0.80 (m, 3H), 0.78 (d, J=6.6 Hz, 3H), 0.52 (s, 6H), 0.51 (s, 3H),
0.50 ppm (s, 3H). 13C NMR (75 MHz, CDCl3), major diastereomer: d=
172.7, 170.2, 138.4, 133.8, 129.1, 127.8, 78.8, 63.9, 60.4, 36.7, 32.9, 31.3,
27.8, 21.2, 19.8, 18.2, 14.1, ꢀ0.7, ꢀ1.9 ppm; minor diastereomer: d=
172.3, 170.4, 138.8, 133.7, 129.1, 127.9, 78.4, 63.1, 60.5, 35.2, 32.6, 31.0,
30.2, 21.2, 19.9, 18.5, 14.1, ꢀ0.3, ꢀ2.7 ppm; MS (ESI): m/z (%): 442 (75)
[M+Na]+; HRMS [M+Na]+ C21H33N3O4SiNa calcd: 442.2138; found:
442.2126.
Ethyl
6-acetoxy-4-azido-5-(dimethylphenylsilyl)-6-phenylhexanoate
(15d): Prepared according to general procedure C from ethyl ester 7
(52 mg, 0.25 mmol), allylsilane 13d (162 mg, 0.50 mmol), benzenesulfo-
A
(4S,5R,6S)-Ethyl
6-acetoxy-4-azido-5-(triisopropylsilyl)-6-phenylhexa-
DTBHN (7 mg, 0.04 mmol) added by 3% portion every 90 min. The
crude was purified by chromatography (hexane/EtOAc 95:5) to afford a
yellow oil (syn/anti >95:5, 74 mg, 65%).IR (neat): nmax =3440, 2105,
noate ethyl ester (18b): Prepared according to general procedure C from
ethyl ester 7 (92 mg, 0.44 mmol), allylsilane 17c (77 mg, 0.22 mmol), 3-
pyridylsulfonylazide (124 mg, 0.67 mmol), (Bu3Sn)2 (0.17 mL, 0.32 mmol),
and DTBHN (14 mg, 0.08 mmol) added by 3% portion every 2 h. The
crude was purified by chromatography (hexane/EtOAc 95:5) to afford a
1
1737, 1373, 1229, 1112, 1033 cmꢀ1; H NMR (300 MHz, CDCl3): d=)7.42–
7.35 (m, 5H), 7.31–7.18 (m, 5H), 6.05 (d, J=3.4 Hz, 1H), 4.03 (q, J=
Chem. Eur. J. 2008, 14, 2744 – 2756
ꢀ 2008 Wiley-VCH Verlag GmbH & Co.KGaA, Weinheim
2753